Outpatient parenteral antimicrobial therapy for patients with <i>Enterococcus faecalis</i> endocarditis using continuous infusion IV benzylpenicillin plus IV ceftriaxone

Simon Briggs(Auckland City Hospital), Simon C. Dalton(Christchurch Hospital), Genevieve Walls(Middlemore Hospital), Rebekah Lane(Auckland City Hospital), Hasan Bhally(North Shore Hospital), Patrick O. Campbell(Christchurch Hospital), Eamon Duffy(Auckland City Hospital), Stephen McBride(Counties Manukau District Health Board), Matthew Broom(North Shore Hospital)
JAC-Antimicrobial Resistance
September 3, 2024
10.1093/jacamr/dlae168
Cited by 3

Related Papers

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
|PubMed|2001|861
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance
|JAMA|2018|761
The Stripping of the Altars: Traditional Religion in England, c. 1400-c. 1580.
|The American Historical Review|1994|288
The Golden Legend
|Princeton University Press eBooks|2012|246
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study
|Clinical Infectious Diseases|2020|155